Literature DB >> 33760935

[Monitoring of COVID-19 by extending existing surveillance for acute respiratory infections].

Luise Goerlitz1, Kristin Tolksdorf1, Udo Buchholz1, Kerstin Prahm1, Ute Preuß1, Matthias An der Heiden1, Thorsten Wolff2, Ralf Dürrwald2, Andreas Nitsche3, Janine Michel3, Walter Haas1, Silke Buda4.   

Abstract

As part of the national influenza pandemic preparedness, surveillance systems have been established in Germany in addition to the mandatory notifications according to the Protection Against Infection Act. The aim of these systems is the description, analysis, and evaluation of the epidemiology of acute respiratory infections (ARIs), the identification of the circulating viruses, and the trend. Since the beginning of the COVID-19 pandemic, the systems have been expanded to enable monitoring of infections with SARS-CoV‑2.Three systems are presented: GrippeWeb, the primary care sentinel Arbeitsgemeinschaft Influenza with its electronic reporting module SEEDARE, and the ICD-10-based hospital sentinel ICOSARI. With these systems, ARIs can be monitored at the population, outpatient, and inpatient levels. In combination with the monitoring of mortality, these systems provide important information on the frequency of different stages of disease severity in the population. In order to expand the systems to SARS-CoV‑2, only a few adjustments were needed.As the case definitions for ARIs were preserved, historical baselines of the systems can still be used for comparison. All systems are structured in such a way that stable and established reference values are available for calculating weekly proportions and rates.This is an important addition to the mandatory reporting system of infectious diseases in Germany, which depends on the particular testing strategy, the number of tests performed, and on specific case definitions, which are adapted as required.The surveillance systems have proven to be feasible and efficient in the COVID-19 pandemic, even when compared internationally.

Entities:  

Keywords:  Influenza pandemic preparednesss; SARS-CoV-2; Seriousness of disease; Syndromic surveillance; Virological surveillance

Year:  2021        PMID: 33760935      PMCID: PMC7988640          DOI: 10.1007/s00103-021-03303-2

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN: 1436-9990            Impact factor:   1.513


  1 in total

1.  Monitoring the mortality impact of COVID-19 in Europe: What can be learned from 2009 influenza H1N1p mortality studies?

Authors:  Lisa Staadegaard; Robert J Taylor; Peter Spreeuwenberg; Saverio Caini; Lone Simonsen; John Paget
Journal:  Int J Infect Dis       Date:  2020-10-16       Impact factor: 3.623

  1 in total
  1 in total

1.  [The different periods of COVID-19 in Germany: a descriptive analysis from January 2020 to February 2021].

Authors:  Julia Schilling; Kristin Tolksdorf; Adine Marquis; Mirko Faber; Thomas Pfoch; Silke Buda; Walter Haas; Ekkehard Schuler; Doris Altmann; Ulrike Grote; Michaela Diercke
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2021-08-10       Impact factor: 1.513

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.